Consolidation therapy with mitoxantrone, ifosfamide and etoposide with or without rituximab before stem cell transplantation in relapsed diffuse large B-cell lymphoma patients failing second-line treatment

Sandy AmorimHémato-Oncologie, AP-HP – Hôpital Saint-Louis (SLS), Paris, France; ;Université Paris Diderot, Sorbonne Paris Cité, Paris, France;

Isabelle FleuryHémato-Oncologie, AP-HP – Hôpital Saint-Louis (SLS), Paris, France;

Nicolas MounierCHU De l'Archet – Hemato-Oncologie, Nice, France

Stéphanie HarelHémato-Oncologie, AP-HP – Hôpital Saint-Louis (SLS), Paris, France; ;Université Paris Diderot, Sorbonne Paris Cité, Paris, France;

Pauline BriceHémato-Oncologie, AP-HP – Hôpital Saint-Louis (SLS), Paris, France;

Catherine ThieblemontHémato-Oncologie, AP-HP – Hôpital Saint-Louis (SLS), Paris, France; ;Université Paris Diderot, Sorbonne Paris Cité, Paris, France; Correspondence[email protected]

Citations (0)

Keep up to date with the latest research on this topic with citation updates for this article.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Consolidation therapy with mitoxantrone, ifosfamide and etoposide with or without rituximab before stem cell transplantation in relapsed diffuse large B-cell lymphoma patients failing second-line treatment

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Consolidation therapy with mitoxantrone, ifosfamide and etoposide with or without rituximab before stem cell transplantation in relapsed diffuse large B-cell lymphoma patients failing second-line treatment

Citations (0)

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date